We are live on ! Find out more
IAM

Innovis Asset Management Portfolio holdings

AUM $260M
1-Year Est. Return 28.13%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+28.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$24.2M
Cap. Flow
+$3.94M
Cap. Flow %
1.45%
Top 10 Hldgs %
35%
Holding
186
New
25
Increased
37
Reduced
82
Closed
24

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$4.52M
2
ROK icon
Rockwell Automation
ROK
+$4.16M
3
NEM icon
Newmont
NEM
+$3.45M
4
EMR icon
Emerson Electric
EMR
+$3.41M
5
MSFT icon
Microsoft
MSFT
+$2.94M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.32M
2
FCX icon
Freeport-McMoran
FCX
+$3.32M
3
CTVA icon
Corteva
CTVA
+$3.26M
4
DVN icon
Devon Energy
DVN
+$3.24M
5
UNH icon
UnitedHealth
UNH
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 31.6%
2 Healthcare 22.77%
3 Financials 8.72%
4 Energy 6.58%
5 Consumer Staples 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPC icon
76
Genuine Parts
GPC
$18.7B
$483K 0.18%
2,856
-19
-0.7% -$3.11K
IMUX icon
77
Immunic
IMUX
$204M
$467K 0.17%
18,624
+10,547
+131% +$177K
HMC icon
78
Honda
HMC
$41.2B
$467K 0.17%
15,398
-100
-0.6% -$2.82K
IPG
79
DELISTED
Interpublic Group of Companies
IPG
$462K 0.17%
11,979
-69
-0.6% -$2.6K
GEHC icon
80
GE HealthCare
GEHC
$32.2B
$461K 0.17%
5,670
– –
K
81
DELISTED
Kellanova
K
$453K 0.17%
7,154
-94
-1% -$6K
UPBD icon
82
Upbound Group
UPBD
$1.15B
$433K 0.16%
+13,899
New +$406K
GORV
83
DELISTED
Lazydays
GORV
$432K 0.16%
1,246
+8
+0.6% +$2.75K
HD icon
84
Home Depot
HD
$353B
$421K 0.16%
1,355
-14
-1% -$4.14K
DICE
85
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$411K 0.15%
+8,851
New +$306K
KBR icon
86
KBR
KBR
$4.78B
$411K 0.15%
6,314
+34
+0.5% +$2.03K
VEU icon
87
Vanguard FTSE All-World ex-US ETF
VEU
$68.4B
$410K 0.15%
7,539
– –
CRWD icon
88
CrowdStrike
CRWD
$216B
$406K 0.15%
11,064
– –
GERN icon
89
Geron
GERN
$956M
$397K 0.15%
123,669
+61,255
+98% +$174K
PRTS icon
90
CarParts.com
PRTS
$53.7M
$389K 0.14%
9,146
+4,676
+105% +$209K
TGT icon
91
Target
TGT
$67.6B
$388K 0.14%
2,945
-34
-1% -$5.05K
NUE icon
92
Nucor
NUE
$62B
$387K 0.14%
2,362
-13
-0.5% -$1.9K
ABT icon
93
Abbott
ABT
$186B
$382K 0.14%
3,500
– –
AXSM icon
94
Axsome Therapeutics
AXSM
$10.9B
$375K 0.14%
5,221
-5,433
-51% -$401K
DOX icon
95
Amdocs
DOX
$6.24B
$375K 0.14%
3,789
-25
-0.7% -$2.35K
OMC icon
96
Omnicom Group
OMC
$23.4B
$372K 0.14%
3,909
-22
-0.6% -$2.04K
FTNT icon
97
Fortinet
FTNT
$117B
$369K 0.14%
4,875
– –
PEP icon
98
PepsiCo
PEP
$190B
$362K 0.13%
1,956
-4
-0.2% -$746
XLRE icon
99
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.59B
$351K 0.13%
9,312
-132
-1% -$4.87K
MRUS
100
DELISTED
Merus
MRUS
$350K 0.13%
+13,299
New +$291K
2 3
4
5 6

Similar funds

RCGI
Ribbit Capital GP II Palo Alto, California $260M AUM 2.87% 1-Year Est. Return
RBGI
Ribbit Bullfrog GP II Palo Alto, California $258M AUM 33.43% 1-Year Est. Return
AEPLI
AH Equity Partners LSV III Menlo Park, California $262M AUM 59.24% 1-Year Est. Return
PWM
PRW Wealth Management Quincy, Massachusetts $262M AUM 22.64% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
W
WealthOne Albany, New York $248M AUM 17.79% 1-Year Est. Return

Innovis Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Innovis Asset Management held 186 positions worth $271M, up 9.8% from $247M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Innovis Asset Management's Q2 2023 filing shows 25 new, 37 increased, 82 reduced and 24 closed positions. Its largest new stake was DexCom: 37,345 shares worth $4.8M. The largest sale was Pfizer, an estimated $5.32M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Innovis Asset Management's largest Q2 2023 buy was DexCom: 37,345 shares worth $4.8M.
  • Innovis Asset Management added most to Newmont in Q2 2023, an estimated $3.45M increase.
  • Innovis Asset Management's biggest Q2 2023 reduction was Pfizer, cutting an estimated $5.32M.
  • Innovis Asset Management fully exited Freeport-McMoran in Q2 2023, selling an estimated $3.32M.
  • Innovis Asset Management's ten largest holdings make up 35% of its $271M portfolio in Q2 2023.
  • Innovis Asset Management opened 25 new positions and closed 24 in Q2 2023.
  • Innovis Asset Management's portfolio value rose 9.8% quarter-over-quarter to $271M.

Based on Innovis Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.